Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process
Authors: J.S.S. Concha, S. Pena, R. G. Gaffney, B. Patel, M. Tarazi, C. J. Kushner, J.F. Merola, D. Fiorentino, J.P. Dutz, M. Goodfield, F. Nyberg, B. Volc‐Platzer, M. Fujimoto, C.C. Ang, V.P. Werth, Rachel Abuav, Rohit Aggarwal, Nidhi Avashia‐Khemka, Jeffrey P. Callen, Adela Rambi G. Cardones, Sarah S. Chisolm, Benjamin F. Chong, Lorinda Chung, Jennie T. Clarke, M. Kari Connolly, Melissa Costner, Megan Curran, Lyubomir Dourmishev, Lisa A. Drage, Alisa N. Femia, Anthony P. Fernandez, Nicole Fett, Galen Foulke, Andrew G. Franks, Anna Haemel, Yasuhito Hamaguchi, Christopher B. Hansen, Sotonye Imadojemu, Khor Jia Ker, Hee Joo Kim, Drew JB Kurtzman, Christina Lam, Anne E. Laumann, Julie Lin, Jeffery D. Mailhot, Simon J Meggitt, Robert G. Micheletti, Sei‐ichiro Motegi, Yoshinao Muro, Elizabeth O'Brien, Lisa Pappas‐Taffer, Taraneh Paravar, Aurora Parodi, David R. Pearson, Joanie Pinard, Sarika Ramachandran, Lisa G. Rider, Misha Rosenbach, Richard D. Sontheimer, Michael Sticherling, Cristián Andrés Vera Kellet, Ruth Ann Vleugels, David A. Wetter, Yukie Yamaguchi
Journal: British Journal of Dermatology (2019)

The European League Against Rheumatism/American College of Rheumatology classification criteria for inflammatory myopathies are able to classify patients with skin-predominant dermatomyositis (DM). However, approximately 25% of patients with skin-predominant DM do not meet two of the three hallmark skin signs and fail to meet the criteria.To develop a set of skin-focused classification criteria that will distinguish cutaneous DM from mimickers and allow a more inclusive definition of skin-predominant disease.An extensive literature review was done to generate items for the Delphi process. Items were grouped into categories of distribution, morphology, symptoms, antibodies, histology and contextual factors. Using REDCap™, participants rated these items in terms of appropriateness and distinguishing ability from mimickers. The relevance score ranged from 1 to 100, and the median score determined a rank-ordered list. A prespecified median score cut-off was decided by the steering committee and the participants. There was a pre-Delphi and two rounds of actual Delphi.There were 50 participating dermatologists and rheumatologists from North America, South America, Europe and Asia. After a cut-off score of 70 during the first round, 37 of the initial 54 items were retained and carried over to the next round. The cut-off was raised to 80 during round two and a list of 25 items was generated.This project is a key step in the development of prospectively validated classification criteria that will create a more inclusive population of patients with DM for clinical research. What's already known about this topic? Proper classification of patients with skin-predominant dermatomyositis (DM) is indispensable in the appropriate conduct of clinical/translational research in the field. The only validated European League Against Rheumatism/American College of Rheumatology criteria for idiopathic inflammatory myopathies are able to classify skin-predominant DM. However, a quarter of amyopathic patients still fail the criteria and does not meet the disease classification. What does this study add? A list of 25 potential criteria divided into categories of distribution, morphology, symptomatology, pathology and contextual factors has been generated after several rounds of consensus exercise among experts in the field of DM. This Delphi project is a prerequisite to the development of a validated classification criteria set for skin-predominant DM.